Tag: Health care industry

Biotech’s recovery isn’t a ‘head fake.’  These 3 stocks could lead the next leg up

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

AstraZeneca’s trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?

Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC

AstraZeneca stock dives 9% after heart drug trial misses target

Healthy Returns: Employers aren’t expanding coverage of GLP-1 obesity drugs – many are finding ways around it

Jim Cramer says these are the 5 stocks to buy during this market rotation

Ebola outbreak containment hampered by USAID closure, experts say

Jim Cramer says this former Covid market darling is finally investable again

Healthy Returns: Walmart, CVS step in to help seniors navigate Medicare coverage of obesity drugs